All Comparisons/Craniocatch vs Allisone

VNDRIQ — Vendor Comparison

Craniocatch vs Allisone

Side-by-side comparison of BAA status, PHI exposure, AI training risk, HIPAA suitability, and VNDRIQ governance scores.

Craniocatch41
Allisone41

Craniocatch

Dental Imaging AI

Verification pending

Allisone

Dental Imaging AI

Verification pending

VNDRIQ Scores

41

Overall

Privacy Score36
Governance Score37
Healthcare Readiness35
AI Risk Score55

41

Overall

Privacy Score36
Governance Score37
Healthcare Readiness35
AI Risk Score55

Approval Tier

Restricted / Review Required
Restricted / Review Required

BAA Status

No publicly available Business Associate Agreement (BAA) was identified; the company is headquartered in Turkey and lacks verified FDA clearance for US clinical use.
No public evidence of a Business Associate Agreement (BAA) was found in the search results; the company primarily highlights its CE Class IIa medical device certification for the European market.

PHI Exposure Risk

High
High

AI Training Risk

Medium
Medium

HIPAA Risk Level

High
High

Review Frequency

Quarterly

Quarterly

Recommended Use

Educational and research purposes; clinical use is currently restricted in the United States due to the absence of FDA marketing authorization.

AI-assisted interpretation of 2D dental radiographs and visual patient education to improve treatment plan acceptance.

Restrictions

Lacks verified FDA 510(k) clearance for clinical deployment within the United States as of recent regulatory reviews.

Intended for use by qualified dental surgeons only; AI findings must be verified by a practitioner. US-based practices must verify HIPAA compliance and BAA availability before use.

Executive Summary

Craniocatch

Dental Imaging AI

Craniocatch is classified as Restricted / Review Required with a BAA status of No publicly available Business Associate Agreement (BAA) was identified; the company is headquartered in Turkey and lacks verified FDA clearance for US clinical use.. PHI exposure is rated High and AI training risk is Medium. Educational and research purposes; clinical use is currently restricted in the United States due to the absence of FDA marketing authorization.

36

Privacy

37

Governance

35

Healthcare

55

AI Risk

Allisone

Dental Imaging AI

Allisone is classified as Restricted / Review Required with a BAA status of No public evidence of a Business Associate Agreement (BAA) was found in the search results; the company primarily highlights its CE Class IIa medical device certification for the European market.. PHI exposure is rated High and AI training risk is Medium. AI-assisted interpretation of 2D dental radiographs and visual patient education to improve treatment plan acceptance.

36

Privacy

37

Governance

35

Healthcare

55

AI Risk

Recommended For

Craniocatch

Educational and research purposes; clinical use is currently restricted in the United States due to the absence of FDA marketing authorization.

Currently under review — not recommended for active PHI deployment

Allisone

AI-assisted interpretation of 2D dental radiographs and visual patient education to improve treatment plan acceptance.

Currently under review — not recommended for active PHI deployment

Governance Considerations

Craniocatch

PHI exposure is elevated. Review data flow documentation.

Quarterly reviews are required — establish internal review cadence.

Restrictions noted: Lacks verified FDA 510(k) clearance for clinical deployment within the United States as of recent regulatory reviews.

Allisone

PHI exposure is elevated. Review data flow documentation.

Quarterly reviews are required — establish internal review cadence.

Restrictions noted: Intended for use by qualified dental surgeons only; AI findings must be verified by a practitioner. US-based practices must verify HIPAA compliance and BAA availability before use.

Questions to Ask Before Approval

01

Has the vendor executed a Business Associate Agreement (BAA) with your organization?

02

Does the vendor use customer data to train AI models? Can you opt out?

03

Where is PHI stored, processed, and transmitted?

04

What data retention and deletion policies apply to your PHI?

05

Has the vendor undergone a third-party HIPAA or SOC 2 audit?

06

What is the vendor's incident response and breach notification process?

07

Does the vendor offer audit logging for PHI access?

08

What subprocessors have access to PHI through this vendor?

Request Vendor Evaluation

Get a structured risk assessment for any vendor.

Request Benchmark Report

Compare vendors across your full stack.

Book Governance Assessment

Talk to a VNDRIQ governance specialist.